$OKE
ONEOK INC /NEW/

2024 Q2 Form 10-Q Financial Statement

#000103968424000035 Filed on May 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $4.894B $4.781B
YoY Change 31.14% 5.75%
Cost Of Revenue $2.891B $2.897B
YoY Change 16.48% -13.44%
Gross Profit $2.003B $1.884B
YoY Change 60.24% 60.48%
Gross Profit Margin 40.93% 39.41%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $262.0M $254.0M
YoY Change 54.12% 56.79%
% of Gross Profit 13.08% 13.48%
Operating Expenses $774.0M $820.0M
YoY Change 50.88% 79.04%
Operating Profit $1.229B $1.064B
YoY Change 66.76% -28.92%
Interest Expense -$210.0M $300.0M
YoY Change -216.67% 80.72%
% of Operating Profit -17.09% 28.2%
Other Income/Expense, Net $4.000M $7.000M
YoY Change -69.23% -12.5%
Pretax Income $1.023B $847.0M
YoY Change 66.88% -38.58%
Income Tax $243.0M $208.0M
% Of Pretax Income 23.75% 24.56%
Net Earnings $780.0M $639.0M
YoY Change 66.67% -39.08%
Net Earnings / Revenue 15.94% 13.37%
Basic Earnings Per Share $1.33 $1.09
Diluted Earnings Per Share $1.33 $1.09
COMMON SHARES
Basic Shares Outstanding 583.6M shares 583.2M shares
Diluted Shares Outstanding 585.8M shares 585.7M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $36.00M $65.00M
YoY Change -66.04% -90.44%
Cash & Equivalents $36.00M $65.00M
Short-Term Investments
Other Short-Term Assets $270.0M $212.0M
YoY Change 10.66% 34.18%
Inventory $671.0M $798.0M
Prepaid Expenses
Receivables $1.330B $1.699B
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.475B $2.950B
YoY Change 32.85% 14.83%
LONG-TERM ASSETS
Property, Plant & Equipment $33.42B $32.81B
YoY Change 65.18% 63.71%
Goodwill $5.112B $5.056B
YoY Change
Intangibles $1.297B $1.311B
YoY Change
Long-Term Investments $1.937B $1.939B
YoY Change 118.87% 145.75%
Other Assets $299.0M $327.0M
YoY Change -4.47% 3.48%
Total Long-Term Assets $42.06B $41.44B
YoY Change 89.67% 89.27%
TOTAL ASSETS
Total Short-Term Assets $2.475B $2.950B
Total Long-Term Assets $42.06B $41.44B
Total Assets $44.54B $44.39B
YoY Change 85.27% 81.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.271B $1.480B
YoY Change 44.43% 37.8%
Accrued Expenses $355.0M $268.0M
YoY Change 57.08% 79.87%
Deferred Revenue $119.0M $99.00M
YoY Change
Short-Term Debt $180.0M $320.0M
YoY Change
Long-Term Debt Due $1.354B $1.200B
YoY Change 140.0%
Total Short-Term Liabilities $3.979B $4.194B
YoY Change 162.29% 92.21%
LONG-TERM LIABILITIES
Long-Term Debt $20.34B $20.45B
YoY Change 59.62% 60.65%
Other Long-Term Liabilities $552.0M $559.0M
YoY Change 67.27% 69.91%
Total Long-Term Liabilities $20.89B $21.01B
YoY Change 59.81% 60.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.979B $4.194B
Total Long-Term Liabilities $20.89B $21.01B
Total Liabilities $24.87B $25.20B
YoY Change 70.47% 65.37%
SHAREHOLDERS EQUITY
Retained Earnings $1.126B $927.0M
YoY Change 58.37% 37.95%
Common Stock $6.000M $6.000M
YoY Change 20.0% 20.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $653.0M $663.0M
YoY Change -5.77% -5.15%
Treasury Stock Shares
Shareholders Equity $16.71B $16.45B
YoY Change
Total Liabilities & Shareholders Equity $44.54B $44.39B
YoY Change 85.27% 81.45%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $780.0M $639.0M
YoY Change 66.67% -39.08%
Depreciation, Depletion And Amortization $262.0M $254.0M
YoY Change 54.12% 56.79%
Cash From Operating Activities $1.430B $596.0M
YoY Change 85.23% -51.19%
INVESTING ACTIVITIES
Capital Expenditures $479.0M $512.0M
YoY Change 57.05% 77.16%
Acquisitions
YoY Change
Other Investing Activities -$277.0M -$1.000M
YoY Change 191.58%
Cash From Investing Activities -$756.0M -$578.0M
YoY Change 89.0% -1329.79%
FINANCING ACTIVITIES
Cash Dividend Paid $578.0M
YoY Change 35.36%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change -100.0%
Cash From Financing Activities -703.0M -$291.0M
YoY Change -25.69% -63.99%
NET CHANGE
Cash From Operating Activities 1.430B $596.0M
Cash From Investing Activities -756.0M -$578.0M
Cash From Financing Activities -703.0M -$291.0M
Net Change In Cash -29.00M -$273.0M
YoY Change -94.95% -159.35%
FREE CASH FLOW
Cash From Operating Activities $1.430B $596.0M
Capital Expenditures $479.0M $512.0M
Free Cash Flow $951.0M $84.00M
YoY Change 103.64% -90.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4781000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4521000000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
2897000000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
3347000000 usd
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
486000000 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
239000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
254000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
162000000 usd
CY2024Q1 us-gaap Taxes Other
TaxesOther
86000000 usd
CY2023Q1 us-gaap Taxes Other
TaxesOther
57000000 usd
CY2024Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
6000000 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
781000000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1064000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1497000000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
76000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
40000000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8000000 usd
CY2024Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
12000000 usd
CY2023Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
18000000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
300000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
166000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
847000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1379000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
208000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
330000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
639000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1049000000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
639000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1049000000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.09
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.34
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.09
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.34
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
584200000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
448100000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
585700000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
449000000.0 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
639000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1049000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
22000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
-7000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-75000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
23000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
6000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
3000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
21000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
12000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
1000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
2000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-95000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
544000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1058000000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
338000000 usd
CY2024Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
1699000000 usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
1705000000 usd
CY2024Q1 us-gaap Materials Supplies And Other
MaterialsSuppliesAndOther
153000000 usd
CY2023Q4 us-gaap Materials Supplies And Other
MaterialsSuppliesAndOther
148000000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
798000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
639000000 usd
CY2024Q1 oke Commodity Exchanges And Imbalances
CommodityExchangesAndImbalances
23000000 usd
CY2023Q4 oke Commodity Exchanges And Imbalances
CommodityExchangesAndImbalances
26000000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
212000000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
252000000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
2950000000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3108000000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
38796000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
38454000000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5989000000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5757000000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
32807000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
32697000000 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
1939000000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1874000000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
5056000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
4952000000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1311000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1316000000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
327000000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
319000000 usd
CY2024Q1 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
8633000000 usd
CY2023Q4 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
8461000000 usd
CY2024Q1 us-gaap Assets
Assets
44390000000 usd
CY2023Q4 us-gaap Assets
Assets
44266000000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1234000000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
484000000 usd
CY2024Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
320000000 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1480000000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1564000000 usd
CY2024Q1 oke Commodity Exchanges And Imbalances Liabilities Current
CommodityExchangesAndImbalancesLiabilitiesCurrent
221000000 usd
CY2023Q4 oke Commodity Exchanges And Imbalances Liabilities Current
CommodityExchangesAndImbalancesLiabilitiesCurrent
244000000 usd
CY2024Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
169000000 usd
CY2023Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
215000000 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
268000000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
381000000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
502000000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
564000000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4194000000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3452000000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
20447000000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
21183000000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2745000000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2594000000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
559000000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
553000000 usd
CY2024Q1 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
3304000000 usd
CY2023Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
3147000000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
20000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
20000 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
609713834 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
583644277 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
609713834 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
583093100 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
6000000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
6000000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16303000000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16320000000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-128000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-33000000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
927000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
868000000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
26069557 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
26620734 shares
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
663000000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
677000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
16445000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
16484000000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44390000000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44266000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
639000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1049000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
254000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
162000000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
76000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
40000000 usd
CY2024Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
78000000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
43000000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
180000000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
285000000 usd
CY2024Q1 us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
0 usd
CY2023Q1 us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
779000000 usd
CY2024Q1 us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
0 usd
CY2023Q1 us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
502000000 usd
CY2024Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
23000000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
18000000 usd
CY2024Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-6000000 usd
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-329000000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
179000000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-20000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-29000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-237000000 usd
CY2024Q1 us-gaap Increase Decrease In Risk Management Assets And Liabilities
IncreaseDecreaseInRiskManagementAssetsAndLiabilities
144000000 usd
CY2023Q1 us-gaap Increase Decrease In Risk Management Assets And Liabilities
IncreaseDecreaseInRiskManagementAssetsAndLiabilities
-26000000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
156000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
157000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
596000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1221000000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
512000000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
289000000 usd
CY2024Q1 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
92000000 usd
CY2023Q1 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
2000000 usd
CY2024Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
25000000 usd
CY2023Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
8000000 usd
CY2024Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 usd
CY2023Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
328000000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-2000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-578000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
47000000 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
578000000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
427000000 usd
CY2024Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
320000000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
0 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
50000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
425000000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-33000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-6000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-291000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-808000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-273000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
460000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
338000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
220000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
680000000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
13.75
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.99
CY2023Q1 us-gaap Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
13.75
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.955
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
16484000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
639000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-95000000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
13.75
CY2024Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
CY2024Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
6000000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.99
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
579000000 usd
CY2024Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
10000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
16445000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6494000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1049000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9000000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
13.75
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
4000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.955
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
427000000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-3000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
7132000000 usd
CY2024Q1 us-gaap Derivative Asset Collateral Obligation To Return Cash Offset
DerivativeAssetCollateralObligationToReturnCashOffset
0 usd
CY2024Q1 oke Derivative Collateral Rightto Reclaim Cash Total
DerivativeCollateralRighttoReclaimCashTotal
129000000 usd
CY2024Q1 us-gaap Derivative Liability Collateral Right To Reclaim Cash Offset
DerivativeLiabilityCollateralRightToReclaimCashOffset
63000000 usd
CY2023Q4 us-gaap Derivative Asset Collateral Obligation To Return Cash Offset
DerivativeAssetCollateralObligationToReturnCashOffset
0 usd
CY2023Q4 oke Derivative Collateral Rightto Reclaim Cash Total
DerivativeCollateralRighttoReclaimCashTotal
41000000 usd
CY2024Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
21000000000 usd
CY2023Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
21400000000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
21700000000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
21700000000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
115000000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
177000000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
177000000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
84000000 usd
CY2024Q1 us-gaap Derivative Liability Collateral Right To Reclaim Cash Offset
DerivativeLiabilityCollateralRightToReclaimCashOffset
63000000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1200000000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
639000000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
584200000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.09
CY2024Q1 us-gaap Dilutive Securities
DilutiveSecurities
0 usd
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1500000 shares
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
639000000 usd
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
585700000 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.09
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1049000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
448100000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.34
CY2023Q1 us-gaap Dilutive Securities
DilutiveSecurities
0 usd
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
900000 shares
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1049000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
449000000.0 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.34
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
76000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
40000000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
150000000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
109000000 usd
CY2024Q1 oke Contractwith Customer Liability Net Additions
ContractwithCustomerLiabilityNetAdditions
98000000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
139000000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
104000000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
46000000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
99000000 usd
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
40000000 usd
CY2023Q1 oke Additional Adjusted Ebitda
AdditionalAdjustedEBITDA
16000000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
924000000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
986000000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
832000000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
735000000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2192000000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5669000000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4781000000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
2897000000 usd
CY2024Q1 us-gaap Direct Operating Costs
DirectOperatingCosts
572000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
254000000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
76000000 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
1939000000 usd
CY2024Q1 us-gaap Assets
Assets
44390000000 usd
CY2024Q1 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
512000000 usd
CY2023Q1 oke Additional Adjusted Ebitda
AdditionalAdjustedEBITDA
16000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4521000000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
3347000000 usd
CY2023Q1 us-gaap Direct Operating Costs
DirectOperatingCosts
296000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
162000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
40000000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
789000000 usd
CY2023Q1 us-gaap Assets
Assets
24464000000 usd
CY2023Q1 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
289000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
639000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1049000000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
300000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
166000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
254000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
162000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
208000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
330000000 usd
CY2024Q1 oke Adjusted Ebitda Unconsolidated Affiliates
AdjustedEBITDAUnconsolidatedAffiliates
101000000 usd
CY2023Q1 oke Adjusted Ebitda Unconsolidated Affiliates
AdjustedEBITDAUnconsolidatedAffiliates
56000000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
76000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
40000000 usd
CY2024Q1 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
15000000 usd
CY2023Q1 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
10000000 usd
CY2024Q1 oke Other Corporate Costsand Noncash Items
OtherCorporateCostsandNoncashItems
-1000000 usd
CY2023Q1 oke Other Corporate Costsand Noncash Items
OtherCorporateCostsandNoncashItems
-7000000 usd
CY2024Q1 oke Adjusted Ebitda
AdjustedEBITDA
1440000000 usd
CY2023Q1 oke Adjusted Ebitda
AdjustedEBITDA
1726000000 usd

Files In Submission

Name View Source Status
0001039684-24-000035-index-headers.html Edgar Link pending
0001039684-24-000035-index.html Edgar Link pending
0001039684-24-000035.txt Edgar Link pending
0001039684-24-000035-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
oke-20240331.htm Edgar Link pending
oke-20240331.xsd Edgar Link pending
oke-20240331_g1.jpg Edgar Link pending
okeq12024exhibit221.htm Edgar Link pending
okeq12024exhibit311.htm Edgar Link pending
okeq12024exhibit312.htm Edgar Link pending
okeq12024exhibit321.htm Edgar Link pending
okeq12024exhibit322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
oke-20240331_cal.xml Edgar Link unprocessable
oke-20240331_def.xml Edgar Link unprocessable
oke-20240331_lab.xml Edgar Link unprocessable
oke-20240331_pre.xml Edgar Link unprocessable
oke-20240331_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable